Express Pharma

Home
- Drug approvals
- Nutraceuticals
- Cosmeceuticals
- Pharma IT
- Policies
- Technology
- Logistics
- HR
- Biotech
- Startup Corner
- AYUSH
- More
Cover Story
Features
Specials
Guest Blogs
Interviews
Editor’s note
Events
- Upcoming Events
- Event Listings
Videos
Downloads
EP Dialogues
- Episode 1
- Episode 2

Likes
Followers
Subscribers
Followers

Likes
Followers
Subscribers
Followers

Sign in

Welcome, Login to your account.

Forget password? Remember me

Sign in

Recover your password.

A password will be e-mailed to you.

Tuesday, June 23, 2026
Home
Digital Issue
Advertise With Us
About Us
- Subscriptions
- Contact Us
Submit Press Release
- Submit Guest Blogs
- Contributors Checklist
Network
Privacy Policy

Express Pharma - Express Pharma

Home
- Drug approvals
- Nutraceuticals
- Cosmeceuticals
- Pharma IT
- Policies
- Technology
- Logistics
- HR
- Biotech
- Startup Corner
- AYUSH
- More
Cover Story
Features
Specials
Guest Blogs
Interviews
Editor’s note
Events
- Upcoming Events
- Event Listings
Videos
Downloads
EP Dialogues
- Episode 1
- Episode 2

Home
Market
M&A activity in lifesciences witness deals worth $2.5 bn
20180331ep21

Return to "M&A activity in lifesciences witness deals worth $2.5 bn"

20180331ep21

SIGNUP FREE NEWSLETTER

Leave this field empty if you're human:

Stay With Us

Facebook Likes
Twitter Followers
Youtube Subscribers
Linkedin Follow us

Express Pharma, first published as Express Pharma Pulse in 1994, is today India’s leading business fortnightly for the pharmaceutical industry. With the patronage of its readers, Express Pharma has grown to become the No.1 Business News Magazine for the pharmaceutical industry. The editorial contents include: news, views, analysis and interviews, under four main segments: Market (The business of pharmaceuticals), Management (Insight for managing pharma), Research (Expertise for drug development) and Pharma Life (HR issues with a pharma focus). Besides this, we bring out periodic specials like the quarterly Pharma Technology Review, Packaging Special and LABNEXT.

SIGNUP FREE NEWSLETTER

Leave this field empty if you're human:

Sign in

Home
- Drug approvals
- Nutraceuticals
- Cosmeceuticals
- Pharma IT
- Policies
- Technology
- Logistics
- HR
- Biotech
- Startup Corner
- AYUSH
- More
Cover Story
Features
Specials
Guest Blogs
Interviews
Editor’s note
Events
- Upcoming Events
- Event Listings
Videos
Downloads
EP Dialogues
- Episode 1
- Episode 2